首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1819729

2021-2031 年北美解剖病理學市場報告（範圍、細分、動態和競爭分析）

North America Anatomic Pathology Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年07月10日 | 出版商:

The Insight Partners | 英文 127 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

解剖病理學市場預計將大幅成長，到 2031 年將達到約 213.9845 億美元，高於 2023 年的 126.9248 億美元。這一成長代表著 2023 年至 2031 年的年複合成長率(CAGR) 為 6.7%。

執行摘要和北美解剖病理學市場概覽

在北美，解剖病理學市場主要分為三個區域：美國、加拿大和墨西哥。該地區被認為是解剖病理學領域的主要參與者，這主要得益於該地區癌症發病率的上升、政府加強癌症篩檢舉措、對精準疾病診斷的日益重視以及對先進醫療保健系統的需求不斷成長。此外，預計該市場將受益於主要產業參與者加強的研發活動以及新產品的推出，這些活動預計將在整個預測期內推動北美解剖病理學市場的成長。

北美解剖病理學市場細分分析

北美解剖病理學市場的分析基於幾個關鍵部分，包括產品和服務、應用和最終用戶。

1. 產品與服務：市場分為服務、儀器和耗材。 2023年，儀器佔據了最大的市場。服務細分市場進一步分為組織病理學和細胞病理學，而儀器細分市場包括切片機、低溫恆溫器、自動染色機、組織處理機和其他相關工具。

2. 應用：市場按應用細分為疾病診斷、藥物研發和其他領域。疾病診斷領域在2023年佔據最大佔有率，反映了解剖病理學在識別各種疾病方面的關鍵作用。

3. 最終使用者：最終使用者細分包括醫院、研究實驗室、診斷實驗室等。醫院在2023年佔據了最大的市場佔有率，凸顯了其在提供解剖病理學服務方面的核心作用。

北美解剖病理學市場展望

在解剖病理學市場中，無論規模大小，越來越多的公司正在實施各種策略，例如地理擴張、推出新產品以及技術進步，以增強收入來源。市場近期發展包括：

2024年5月：Quest Diagnostics與PathAI宣布合作，旨在加速數位和AI病理學創新的整合，以提高癌症和疾病診斷的品質、速度和效率。作為該協議的一部分，Quest將從PathAI Diagnostics收購特定資產，PathAI Diagnostics專注於數位和解剖病理學實驗室服務。
2024年4月：Medline成為PHC集團旗下Epredia的經銷商，Epredia則為解剖病理學領域提供精準癌症診斷與組織診斷解決方案。此次合作使Medline能夠擴展其實驗室產品和設備組合。
2024年4月：StatLab Medical Products收購了總部位於芝加哥的Scientific Device Laboratory，後者專門生產用於解剖病理學和微生物學的診斷玻片及耗材。此次收購增強了StatLab的製造能力和市場影響力。
2024 年 2 月：Hologic Inc 的 Genius 數位診斷系統獲得 FDA 批准，這是一款專為巴氏抹片檢查設計的尖端數位細胞學系統，預計將於 2024 年在歐洲、澳洲和紐西蘭上市後在美國推出。

市場參與者的這些策略舉措預計將對解剖病理學市場的成長做出重大貢獻。

北美解剖病理學市場國家洞察

北美解剖病理學市場主要由美國、加拿大和墨西哥組成，其中美國在2023年佔據最大市場佔有率。癌症仍然是美國主要的公共衛生問題，常見癌症類型包括乳癌、肺癌、攝護腺癌、結腸癌和肝癌。根據美國國家癌症研究所的數據，截至2021年，美國約有1,743萬人患有癌症，預計到2030年，癌症倖存者的數量可能達到2,220萬人。癌症盛行率的上升預計將推動對各種病理診斷測試的需求，包括活體組織切片、細針穿刺、基因檢測和其他創新技術。

此外，美國醫療技術取得了顯著進步，推動了醫療保健領域先進醫療器材的開發。美國解剖病理學市場的公司專注於為病理學程序開發創新且方便用戶使用的儀器和耗材。例如，2023年11月，Illumina公司推出了其液體活體組織切片檢測的新版本TruSight Oncology 500 ctDNA v2，該檢測可以對血液樣本中的循環腫瘤DNA進行全面的非侵入性基因組分析，補充了傳統的組織檢測。 2020年，羅氏公司獲得FDA核准，擴大CINtec PLUS細胞學檢測的用途，以輔助預防子宮頸癌。

這些因素，包括癌症高發病率、主要行業參與者的存在以及醫院和臨床實驗室的高品質基礎設施，預計將進一步促進美國解剖病理學市場的成長。

北美解剖病理學市場公司簡介

北美解剖病理學市場的主要參與者包括羅氏公司（F. Hoffmann-La Roche Ltd）、貝克曼庫爾特公司（Beckman Coulter Inc）、豪洛捷公司（Hologic Inc）、安捷倫科技公司（Agilent Technologies Inc）、BioGenex Laboratories Inc、Diapath SpA、Bio 公司（Agilent Technologies Inc）、BioGenex Laboratories Inc、Diapath SpA、Bio 、默克公司（Merck K HoldingsA）。這些公司正在積極推行市場擴張、產品創新和併購等策略，以增強產品組合併提高市場佔有率。

In North America, the anatomic pathology market is divided into three main regions: the United States, Canada, and Mexico. This region is recognized as a major player in the anatomic pathology sector, primarily due to the increasing incidence of cancer, enhanced government initiatives aimed at cancer screening, a growing emphasis on accurate disease diagnosis, and the rising demand for advanced healthcare systems. Additionally, the market is expected to benefit from heightened research and development activities by key industry players, along with the introduction of new products, which are anticipated to propel the growth of the anatomic pathology market in North America throughout the forecast period.

North America Anatomic Pathology Market Segmentation Analysis

The analysis of the North American anatomic pathology market is based on several key segments, including products and services, applications, and end users.

1. Products and Services: The market is categorized into services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is segmented by application into disease diagnosis, drug discovery and development, and other areas. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various diseases.

3. End Users: The end-user segmentation includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in the delivery of anatomic pathology services.

North America Anatomic Pathology Market Outlook

Companies, both large and small, operating within the anatomic pathology market are increasingly implementing various strategies such as geographic expansion, launching new products, and advancing technology to enhance their revenue streams. Recent developments in the market include:

May 2024: Quest Diagnostics and PathAI announced a collaboration aimed at accelerating the integration of digital and AI pathology innovations to enhance the quality, speed, and efficiency of cancer and disease diagnoses. As part of this agreement, Quest will acquire specific assets from PathAI Diagnostics, which specializes in digital and anatomic pathology laboratory services.
April 2024: Medline became the distributor for Epredia, a member of the PHC Group, which offers solutions for precision cancer diagnostics and tissue diagnostics in the anatomic pathology sector. This partnership allows Medline to expand its portfolio of laboratory products and equipment.
April 2024: StatLab Medical Products acquired Scientific Device Laboratory, a Chicago-based manufacturer of diagnostic slides and consumables for anatomic pathology and microbiology. This acquisition enhances StatLab's manufacturing capabilities and market presence.
February 2024: Hologic Inc received FDA approval for its Genius Digital Diagnostics System, a cutting-edge digital cytology system designed for pap testing, which is set to launch in the US in 2024 after being available in Europe, Australia, and New Zealand.

These strategic initiatives by market players are expected to significantly contribute to the growth of the anatomic pathology market.

North America Anatomic Pathology Market Country Insights

The North American anatomic pathology market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2023. Cancer remains a major public health concern in the US, with prevalent types including breast, lung, prostate, colon, and liver cancers. According to the National Cancer Institute, approximately 17.43 million individuals were living with cancer in the US as of 2021, with projections indicating that the number of cancer survivors could reach 22.2 million by 2030. This increasing prevalence of cancer is expected to drive demand for various pathologic diagnostic tests, including biopsies, fine-needle aspirations, genetic testing, and other innovative techniques.

Moreover, the US has witnessed remarkable advancements in medical technologies, leading to the development of sophisticated medical devices within the healthcare sector. Companies in the US anatomic pathology market are focused on creating innovative and user-friendly instruments and consumables for pathological procedures. For instance, in November 2023, Illumina Inc. launched a new version of its liquid biopsy assay, TruSight Oncology 500 ctDNA v2, which allows for comprehensive noninvasive genomic profiling of circulating tumor DNA from blood samples, complementing traditional tissue-based testing. In 2020, F. Hoffmann-La Roche received FDA approval for the expanded use of the CINtec PLUS Cytology test, aiding in cervical cancer prevention.

These factors, including the high cancer prevalence, the presence of major industry players, and the availability of high-quality infrastructure for hospitals and clinical laboratories, are expected to further bolster the growth of the anatomic pathology market in the US.

North America Anatomic Pathology Market Company Profiles

Key players in the North American anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market share.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. North America Anatomic Pathology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.1.2 Rise in Number of Strategic Initiatives
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
- 5.3.1 Growing Focus on Personalized Medicines
5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence and Machine Learning
5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - North America Analysis

6.1 North America Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 North America Anatomic Pathology Market Forecast Analysis

7. North America Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Anatomic Pathology Market - Country Analysis

10.1 North America
- 10.1.1 North America Anatomic Pathology Market Overview
- 10.1.2 North America Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 United States: North America Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.1.1.1 United States: North America Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.1.1.2 United States: North America Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.1.2 United States: North America Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.1.3 United States: North America Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.2 Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Canada: North America Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.2.1.1 Canada: North America Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.2.1.2 Canada: North America Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.2.2 Canada: North America Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.2.3 Canada: North America Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.3 Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 Mexico: North America Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.3.1.1 Mexico: North America Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.3.1.2 Mexico: North America Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.3.2 Mexico: North America Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.3.3 Mexico: North America Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in North America Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Diapath S.p.A.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio SB
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Merck KGaA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 PHC Holdings Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Anatomic Pathology Market Segmentation
Table 2. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Product and Services
Table 4. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 7. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 8. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 9. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 11. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 12. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 13. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 14. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 16. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 17. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 18. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 19. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 21. Recent Organic Growth Strategies in North America Anatomic Pathology Market
Table 22. Recent Inorganic Growth Strategies in the North America Anatomic Pathology Market
Table 23. Glossary of Terms, North America Anatomic Pathology Market

List Of Figures

Figure 1. North America Anatomic Pathology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. North America Anatomic Pathology Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Anatomic Pathology Market Revenue (US$ Million), 2021-2031
Figure 6. North America Anatomic Pathology Market Share (%) - by Product and Services (2023 and 2031)
Figure 7. Services: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Instruments: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Consumables: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. North America Anatomic Pathology Market Share (%) - by Application (2023 and 2031)
Figure 11. Disease Diagnosis: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Drug Discovery and Development: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. North America Anatomic Pathology Market Share (%) - by End User (2023 and 2031)
Figure 15. Hospitals: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Research Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. North America Anatomic Pathology Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
Figure 20. North America Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in North America Anatomic Pathology Market